World NEWS

Pfizer’s weight loss pill may enter regulatory studies next year, says CEO Albert Bourla

CNBC’s Angelica Peebles interviews Pfizer’s CEO Albert Bourla to discuss the company’s earnings, expectations for its new weight loss drug, and more.

Read More  


Discover more from NEWS Daily

Subscribe to get the latest posts sent to your email.

Show More

Related Articles

Back to top button
WP Twitter Auto Publish Powered By : XYZScripts.com

Discover more from NEWS Daily

Subscribe now to keep reading and get access to the full archive.

Continue reading